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Peptidoglycan was isolated from Bacteroides fragilis with boiling sodium dodecyl sulfate, and some was
treated with pronase to eliminate contaminating protein. This peptidoglycan was chemotactic for rabbit
polymorphonuclear neutrophils and had even greater chemotactic activity along with some chemokinetic
activity after it was partially hydrolyzed with lysozyme. Significant chemotaxis-inhibitory activity was observed
for an acid-precipitable component of the lysozyme-treated crude peptidoglycan of B. fragilis.
Previously, we demonstrated that crude outer membranes
(OM) extracted from Bacteroidesfragilis are chemotactic for
rabbit polymorphonuclear (PMN) neutrophils (1); we also
noted chemotactic activity in the culture supernatant that
was membrane filtered (pore diameter, 0.45 ,um). We have
also demonstrated that certain components of B. fragilis are
either antichemotactic or react with serum to inhibit PMN
neutrophil chemotaxis to the partially hydrolyzed peptido-
glycan (PG) of B. fragilis and direct chemotaxis inhibition to
protein-associated PG fragments of B. fragilis. Since B.
fragilis readily lyses and releases cell envelope fragments
(some of which modulate PMN neutrophils) these fragments
might be acting as a smoke screen to interfere with the
normal inflammatory response long enough for the bacteria
to initiate an abscess.
We noticed considerable variation in chemotaxis induced
by different OM preparations from B. fragilis. All crude OM
and mixed membranes (pelleted from culture supernatant at
40,000 x g for 45 min) showed a definite increase in
chemotactic activity following treatment with lysozyme,
even OM isolated from a mucoid colony phase variant (Table
1). Therefore, we isolated the PG from B. fragilis VPI 9032
which had been grown in Trypticase (BBL Microbiology
Systems, Cockeysville, Md.)-yeast extract-glucose broth
under O2-free CO2 for 24 h at 37°C (11). Bacteria (8 liters of
culture) were harvested by centrifugation at 12,100 x g for
20 min at 4°C and washed twice in phosphate-buffered saline
(pH 7.2). Either whole bacteria or the first pellet from the
OM extraction procedure of Kasper and Seiler (7) was
suspended in distilled water (approximately 100 ml) and
added dropwise to 300 ml of boiling 4% (wt/vol) sodium
dodecyl sulfate with constant stirring (10). After being boiled
for an additional 10 min, the solution was cooled to luke-
warm and centrifuged at 36,000 x g for 1 h at 20°C. The
pellet was suspended in distilled water and recentrifuged;
this step was repeated five times. The final pellet was
resuspended in 60 ml of distilled water, sonicated for 30 s,
and lyophilized. This material contained 11% protein as
assayed by the procedure of Lowry et al. (8). Another batch
(150 mg) of crude PG was suspended in 60 ml of 0.01 M Tris
hydrochloride buffer (pH 7.4), sonicated for 30 s, and treated
with 3 mg of pronase (Sigma Chemical Co., St. Louis, Mo.)
at 37°C for 30 min. The suspension was centrifuged at 36,000
x g for 1 h at 20°C, suspended in 60 ml of distilled water, and
lyophilized. The pronase-treated PG contained 1% protein.
* Corresponding author.
The PG were suspended (0.5 mg/ml) in 0.01 M Tris hydro-
chloride buffer (pH 7.4), and 1 mg of lysozyme (Sigma) was
added per 50 mg of PG. The suspensions were incubated at
37°C for 15 h and then centrifuged at 36,000 x g for 1 h at
20°C. The pellet was designated pellet A. The supernatant
was adjusted to pH 3.7 with acetic acid and was centrifuged
at 36,000 x g for 1 h to pellet muramyl dipeptides and
muramyl dipeptide-linked lipoprotein (3). This pellet was
designated pellet B.
Adult New Zealand White rabbit peritoneal exudate cells
were elicited with 0.1% (wt/vol) glycogen in sterile saline and
harvested in sterile heparinized saline (5 U/ml) as described
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FIG. 1. Dose-dependent chemotaxis of rabbit peritoneal PMN
neutrophils induced by the lysozyme-treated B. fragilis PG pellet.
The pellet from 21.5 mg (dry weight) of B. fragilis PG treated with
430 ,ug of lysozyme at 37°C for 15 h and then centrifuged 36,000 x
g for 1 h was suspended in 1 ml of distilled water. 0. Chemotactic
index + standard error of the mean; *, total number of PMN
neutrophils penetrating .10 ,um into six high-power fields (three
random fields per filter).
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FIG. 2. Effects of lysozyme treatment on crude and pronase-treated B.fragilis PG components. HBSS, Negative control; f-MLP, positive
control. (A and C) Crude PG; (B and D) pronase-treated PG. Bars: 1, untreated PG; 2, pellet A of lysozyme-treated PG; 3, pellet A plus
f-MLP; 4, pellet B of lysozyme-treated PG; 5, pellet B plus f-MLP. In panels A and B the chemotactic index ±+ standard error of the mean
is given, and in panels C and D the total number of PMN neutrophils penetrating .-10 ptm into six high-power fields (three random fields per
filter) is given.
before (1). Cells were washed twice with sterile physiologi-
cal saline. Wright-stained smears and wet-mount differential
counts revealed that the suspensions contained at least 98%
PMN neutrophils. Appropriate dilutions were made in
Hanks balanced salt solution (HBSS) containing 0.5%
(wt/vol) bovine serum albumin. Chemotaxis was measured
by a modified Boyden chamber assay (2) by using pretested
membrane filters (diameter, 25 mm; pore diameter, 0.8 pLm).
HBSS (1 ml) containing 2.5 x 106 neutrophils was added to
the upper compartment, and 1 ml of HBSS containing
chemoattractant was added to the lower compartment.
Chambers were incubated at 37°C for 1 h. Duplicate cham-
bers were incubated for each sample tested. Chambers were
disassembled, and filters were fixed in 100% isopropanol,
stained with hematoxylin (1), and mounted on microscope
slides with immersion oil. The chemotactic index was calcu-
lated as described before (6). Previously, we demonstrated
that crude OM is chemotactic for rabbit PMN neutrophils by
showing that neutrophils move toward an OM gradient and
that the effect is dose-dependent chemotaxis (1). Lysozyme-
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TABLE 1. Rabbit PMN neutrophil chemotaxis produced by
B. fragilis crude OM
Chemotaxin ~~~Chemotactic Total cells/sixChemotaxin index" high-powerfields
HBSS 2.22 + 1.75 0
OM VPI 2553 1.67 + 1.676 2
OM VPI 2553 (lysozyme-treated) 17.61 + 1.31' 129
OM VPI 9032 1.67 + 1.67" 2
OM VPI 9032 (lysozyme-treated) 14.11 + 0.90' 80
OM VPI 9032m" 13.38 ± 0.94' 38
OM VPI 9032m" (lysozyme-treated) 16.51 ± 1.51' 42
" Chemotactic index reported as average penetration of membrane filters in
micrometers + standard error of the mean.
' No significant (P > 0.05) chemotaxis compared with HBSS control.
'Significant (P < 0.01) chemotaxis compared with HBSS control.
d Mucoid colony phase variant (VPI 9032m) was isolated from a mouse
subcutaneous abscess produced by inoculating the mouse with translucent
VPI 9032.
treated PG pellet A showed similar dose-dependent chemo-
taxis (Fig. 1); at 12.5 l.l/ml the chemotactic index was
significantly (P < 0.05) greater than that for the HBSS
control, and the higher concentrations were significantly (P
< 0.01) more chemotactic. There was also positive direc-
tional locomotion of PMN neutrophils toward an increasing
gradient of the lysozyme-treated PG (Table 2). Chemokinetic
activity was also observed in increasing penetration of filters
by neutrophils as the concentration of the reactant was
increased in the absence of a gradient (values in boldface
type). Expected values due to chemokinesis alone were
calculated by the method of Zigmond and Hirsch (15).
The effects of lysozyme treatment on the crude and
pronase-treated PG of B. fragilis are shown in Fig. 2.
Partially hydrolyzed PG (A2 and B2) was significantly (P <
0.01) more chemotactic than unhydrolyzed PG was (Al and
Bi). There appeared to be some chemotactic inhibitory
activity in the protein associated with the crude PG; i.e.,
there was no significant increase of total chemotactic activity
when formylmethionyl-leucyl-phenylalanine (f-MLP) was
added to the partially hydrolyzed crude PG (A2; compare A3
and A2). However, there was a significant increase in total
chemotactic activity when f-MLP was added to the partially
hydrolyzed pronase-treated PG (B2; compare B3 and B2).
Pellet B (A4, B4, C4, and D4; possible lipoprotein-containing
pieces of PG) appeared to have little chemotactic activity.
TABLE 2. Directed locomotion of rabbit PMN neutrophils
induced by established gradients of B. fiagilis VPI 9032 lysozyme-
treated PG pellet
Directed locomotion with concn (ull/mI) of PG
Concn (>I/ml) of above filter":
PG below filter
0 10 20 30
0 0 10.3 (9.8) 10.6 (12.3) 10.2 (13.1)
10 12.0 (0.2) 10 10.0 (12.4) 11.4 (13.1)
20 13.1 (0.4) 12.7 (10.1) 12.5 11.4 (13.2)
30 13.9 (0.6) 12.0 (10.2) 11.4 (12.5) 13.2
"Directed locomotion was measured as the chemotactic index (average
distance traveled per PMN neutrophil from the top of the membrane filter
toward the bottom). The numbers in parentheses are theoretical values
expected on the basis of chemokinetic activity. The table field is divided into
the negative gradient (upper right) and the positive gradient (lower left) of
chemotaxin by homologous values (boldface).
However, when f-MLP was added to pellet B from crude PG
(A5 and C5) and to pellet B from the pronase-treated PG (B5
and D5), the results further suggested that the protein
associated with the PG has chemotaxis-inhibitory activity.
Muramyl dipeptides from Mycobacterium tuberculosis
have adjuvant activity (13), inhibit macrophage migration
(9), induce epithelioid granuloma formation (5, 12), and
cause uveitis in rabbits (14). Adjuvant activity has also been
demonstrated for muramyl dipeptides of Escherichia coli,
Bacillus cereus, Micrococcus roseus, and Staphylococcus
epidermidis (4). Therefore, the possibility that the effects of
lysozyme-treated PG components of B. fragilis on phago-
cytes are involved in the initiation of subcutaneous ab-
scesses does have precedent. The presence of a protein
component that inhibits chemotaxis (Fig. 2) might help
initiate production of subcutaneous abscesses by interfering
with phagocytic clearing of the infection site long enough to
allow formation of the abscess.
This study was supported by Public Health Service grant A118404
from the National Institute of Allergy and Infectious Diseases.
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